Top compounds associated with response to MARK1


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 2e-07
mRNA NVP-BEZ235 GDSC1000 pan-cancer AAC -0.2 3e-07
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC 0.2 5e-07
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.19 7e-07
mRNA KPT185 CTRPv2 pan-cancer AAC 0.2 1e-06
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.19 1e-06
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA SB-525334 CTRPv2 pan-cancer AAC 0.18 4e-06
mRNA CI-976 CTRPv2 pan-cancer AAC 0.19 4e-06
mRNA AZD6482 GDSC1000 pan-cancer AAC -0.17 5e-06
Download CSV